127 stories
All topics
Dave Bell is the beloved Santa Claus of Powhatan, Virginia. This year he gave a very different kind of gift: he donated one of his kidneys to an anonymous stranger, losing 40 pounds to qualify—and wore his Santa hat as he recovered in the hospital.
On 2 July 2026, the FDA expanded the CRISPR gene therapy Casgevy to children as young as two with sickle cell disease or transfusion-dependent beta thalassemia — offering a one-time treatment before years of cumulative damage set in.
John Adesoye grew up in a poor farming family in Nigeria and never expected to attend university. At 64, the father of five graduated as a nurse in Bristol, UK—having studied at the same university as his son—and landed a job at Southmead Hospital.
At the ASCO 2026 conference, an international phase 3 trial showed the daily pill daraxonrasib roughly doubled survival in advanced pancreatic cancer — cracking a genetic target long considered “undruggable.”
A peer-reviewed study in Nature (May 2026) describes Google DeepMind’s multi-agent “AI co-scientist,” built on Gemini, which generated hypotheses across three biomedical problems — including drug repurposing for acute myeloid leukemia that researchers then validated experimentally in the lab.
Gavi reported that HPV vaccination in lower-income countries has protected 86 million girls and is estimated to prevent 1.4 million cervical cancer deaths — with over a million already averted — reaching a major coverage target ahead of schedule.
Reported in Nature in May 2026, Robin — a multi-agent research system built by FutureHouse — helped identify a promising treatment lead for dry age-related macular degeneration, pinpointing a cellular process to target and proposing a drug candidate not previously considered, with scientists kept firmly in the loop.
A sweeping review in the British Journal of Sports Medicine pooling data from tens of thousands of people found that exercise reduces depression and anxiety as much as — or more than — medication or talk therapy, with the biggest gains in young adults and new mothers.
Sir Adrian Hill of Oxford’s Jenner Institute received the 2026 European Inventor Award for the R21/Matrix-M malaria vaccine, a low-cost shot with 75–80% efficacy now being rolled out across more than 20 African countries.
Researchers at the University of Warwick discovered how bacterial enzymes use molecular “docking domains” to assemble anti-cancer compounds, opening the door to engineering new, more precise cancer therapies.
A UK trial published in JAMA Psychiatry found that tocilizumab, an anti-inflammatory drug that blocks interleukin-6, eased depression, anxiety and fatigue — an early but promising step toward treatments matched to a person’s biology.
Described in Nature Cancer in April 2026, PRET — built by a team led by Prof. Li Xiaomeng at HKUST with Guangdong Provincial People’s Hospital and Harvard Medical School — brings “in-context learning” to pathology, recognizing 18 cancer types from just one to eight reference slides, with accuracy that matched or beat expert pathologists in key tasks.
Published in Nature on June 18, 2026, two independent AI systems — MIRA, developed by Jakob Kather and colleagues, and Google’s AMIE — proved at least as capable as physicians across diagnosis and treatment reasoning, pointing toward tools that support rather than replace doctors.
University of Cambridge physicists built the first LEDs from lanthanide nanoparticles that are natural electrical insulators, using organic molecular "antennas" to feed them energy at over 98% efficiency — opening a path to ultra-pure infrared light for medical imaging.
On 8 May 2026, the WHO reported that malaria vaccines averted roughly one in eight deaths among eligible young children in Ghana, Kenya and Malawi — powerful evidence as the vaccines reach 25 African countries.
Japanese researchers engineered hybrid vitamin K compounds, one about three times better than natural vitamin K at coaxing neural stem cells into becoming neurons, hinting at future regenerative treatments for diseases like Alzheimer’s and Parkinson’s.
Google DeepMind described Co-Scientist, a Gemini-based multi-agent system that generates and tests scientific hypotheses, after a Stanford team used it to surface a drug candidate that blocked 91 percent of a scarring response in lab tests.
Nature reports that AI-powered brain-computer interfaces are advancing from small clinical trials toward real-world use, with one patient decoding Mandarin at 300 characters per minute and another controlling devices by thought, alongside new ethics guidelines.
Dawn Zuidgeest-Craft spent decades raising four children before finally chasing her lifelong dream. At 72, she graduated from medical school as her institution’s oldest-ever graduate—and is heading into residency in Michigan.
Provisional CDC data released in May 2026 estimate about 69,973 US drug overdose deaths for the 12 months ending December 2025 — a roughly 14% drop and a third straight year of decline, the lowest level since 2019.
New evidence published in The Lancet and announced by the WHO on 8 May 2026 found that the RTS,S malaria vaccine averted about one in eight child deaths in Ghana, Kenya and Malawi over four years, confirming its life-saving impact.
In April 2026, the FDA approved Otarmeni, the first gene therapy for inherited hearing loss caused by OTOF gene variants. In the CHORD trial, 16 of 20 patients met the hearing-improvement endpoint, and Regeneron will offer it free in the US.
The WHO’s Big Catch-Up initiative delivered more than 100 million vaccine doses to 18.3 million children across 36 countries between 2023 and 2025, including 12.3 million who had never received any vaccine.
Researchers at McMaster University built a generative AI called SyntheMol-RL that designed a structurally new antibiotic, synthecin, which controlled drug-resistant Staphylococcus aureus wound infections in mouse tests.
A UCL and Great Ormond Street Hospital study found that the gene therapy Luxturna can strengthen the visual pathways of young children with inherited blindness, with the greatest gains when treatment comes early in brain development.
Researchers reported that madecassic acid — derived from the long-used herb Centella asiatica (gotu kola) — disrupts drug-resistant bacterial infections in lab studies, suggesting a new lead against the antimicrobial-resistance crisis.
A five-year vaccination project at Elanora on the Gold Coast has immunized more than 500 koalas against chlamydia, cutting disease-related hospital admissions by 75 percent. Once-devastated koalas are now thriving, with 41 joeys and 13 “grand-joeys” born.
At the 2026 AACR meeting, Memorial Sloan Kettering researchers reported that a personalized mRNA pancreatic-cancer vaccine triggered immune responses lasting up to six years, with most responders still alive — a hopeful sign against one of the deadliest cancers.
A joint WHO–Gavi analysis released in April 2026 found that measles vaccination averted nearly 20 million deaths in Africa between 2000 and 2024, as coverage rose from 5% to 55% across the region.
Scientists at Great Ormond Street Hospital created the first lab-grown oesophagus and successfully transplanted it into minipigs, restoring swallowing function without immune suppression.
Nobel laureate Shinya Yamanaka reflects on 20 years of iPSC research as the technology now enables corneal cell transplants to treat blindness, eliminating the need for embryonic stem cells.
Machine learning algorithms have successfully predicted the effectiveness of drug compounds for Alzheimer's and cancer, drastically compressing the traditionally years-long drug discovery process.
The FDA has approved suzetrigine (Journavx), a groundbreaking non-opioid pain medication that works by blocking sodium channels in pain-sensing nerves, offering millions of patients effective pain relief without addiction risk.
FDA approval of elinzanetant (Lynkuet) marks a breakthrough in menopause care, offering women effective relief from hot flashes and night sweats without the risks of hormone replacement therapy.
Scientists have used AI to design smart DNA-based drugs that can identify and target cancer cells with extreme precision while leaving healthy cells untouched, potentially transforming cancer treatment by minimizing the devastating side effects of conventional chemotherapy.
An mRNA-based malaria vaccine developed by Oxford and BioNTech has demonstrated 95% efficacy in a Phase 3 trial involving 22,000 children across six African nations, far surpassing existing vaccines and offering hope for eliminating the disease.
A consortium of tech companies and universities has released an open-source AI translation model supporting 250 low-resource languages, enabling 1.5 billion people to access online content, healthcare information, and educational materials in their native tongues.
On 1 April 2026, the FDA approved Eli Lilly’s Foundayo (orforglipron), a once-daily oral GLP-1 for adults with obesity — a needle-free option that, in the ATTAIN-1 trial, helped people lose an average of 12.4% of their body weight.
Researchers at Great Ormond Street Hospital and University College London have created the first lab-grown oesophagus, demonstrating it can safely replace a full section of the organ and restore normal function without immunosuppression.
A pioneering treatment applies stem cells from the mother's placenta to her baby's spine during fetal surgery, showing remarkable results in repairing spina bifida before birth and reducing the need for postnatal interventions.
Researchers at Duke University have developed an ultrafast photodetector capable of sensing light across the entire electromagnetic spectrum, generating a signal in just 125 picoseconds — opening applications from medical imaging to telecommunications.
Butterfly Network won FDA clearance for a blind-sweep AI tool that estimates gestational age from a handheld ultrasound in about a minute, with deployments in Sub-Saharan Africa backed by the Gates Foundation already serving hundreds of clinics.
Cognita CXR, a generative vision-language AI model for chest X-ray interpretation, has received FDA Breakthrough Device Designation. Internal validation showed radiologists using the tool achieved 16-65% enhanced detection of significant findings and 18% faster interpretation.
In March 2026, the FDA approved Kresladi, the first gene therapy for children with severe leukocyte adhesion deficiency type I. In the trial led partly at UCLA, all nine treated patients survived without a bone-marrow transplant.
Researchers from UCL and Great Ormond Street Hospital have created the first lab-grown oesophagus that safely replaces a full section of the organ and restores normal swallowing function — without requiring immunosuppression.
Enlicitide, a new oral pill developed by Merck, reduced LDL cholesterol by about 60% in a major phase 3 trial — matching the effectiveness of injectable therapies. The FDA has added the drug to its program for ultra-fast reviews.
Shay Taylor, who worked as a janitor at Yale New Haven Hospital for nearly a decade starting at age 18, has matched for residency in anesthesiology at the same hospital. Her mother's illness inspired her journey into medicine.
Clinomic's AI agent "Mona" is being deployed in intensive care units to help doctors and nurses manage critical patients by consolidating and visualizing patient data in real time, representing AI's shift from experimental to essential healthcare infrastructure.
The FDA approved Corcept Therapeutics' relacorilant (Lifyorli) on March 25, 2026, giving women with platinum-resistant ovarian cancer a new option that extended median survival to 16 months in a pivotal trial.
On 25 March 2026, the FDA approved Avlayah, the first biologic engineered to cross the blood-brain barrier to treat the neurological effects of Hunter syndrome — a rare childhood disorder — after a trial showed a 91% drop in a key disease marker in the brain.
A new in-womb treatment using stem cells from the mother's placenta to treat spina bifida has shown significant potential in improving children's mobility and quality of life, according to research published in the Lancet.
Zorevunersen has shown up to 91% fewer seizures in children with Dravet syndrome over three years, according to results published in the New England Journal of Medicine by Prof Helen Cross at Great Ormond Street Hospital.
Martha's Rule has generated over 10,000 helpline calls since September 2024, with 1,885 patients receiving treatment changes and 446 potentially life-saving interventions. Named after Martha Mills who died of sepsis in 2021.
A study of over 246,000 adults with heart disease found that shingles vaccination was associated with a 46% reduction in major cardiac events and a 66% reduction in all-cause mortality within one year.
Compass Pathways reported positive results from Phase 3 trials of COMP360, a synthetic psilocybin treatment for depression, potentially making it the first psilocybin-based medication approved in the U.S.
A new AI system published in Nature can diagnose rare diseases by integrating clinical data, genetic information, and medical literature searches. The system provides its underlying reasoning, helping doctors understand its conclusions. For patients who often wait years for a diagnosis, the technology could dramatically shorten the diagnostic odyssey.
Research shows the shingles vaccine may double as a heart protector, cutting major cardiac events by 46% and deaths by 66% within a year in people already at high cardiovascular risk.
Medicines for Malaria Venture and deepmirror launched dd4gh in March 2026, a free AI drug-discovery platform giving researchers in resource-limited settings predictive and generative tools to design compounds against malaria, TB and neglected tropical diseases.
Rentosertib, developed by Insilico Medicine as the first drug whose biological target and molecular design were both discovered by generative AI, improved lung function versus placebo in a Phase IIa trial for idiopathic pulmonary fibrosis and received its official generic name.
The FDA approved Neffy, the first needle-free nasal epinephrine spray for children aged 4 and older. The breakthrough represents the first major update to emergency allergy treatment in over 30 years, eliminating the fear and complexity of injectable epinephrine for the one in 13 children affected by food allergies.
The UK Biobank completed over one billion medical scans from 100,000 volunteers, creating the most comprehensive atlas of the human body ever assembled. Early analysis revealed that heart disease and brain disease often co-occur, suggesting cardiovascular health may protect against dementia.
The FDA approved lenacapavir (Yeztugo), a twice-yearly injectable PrEP medication that prevents nearly all HIV transmission. The drug addresses major barriers to daily pill-based prevention, including stigma and adherence challenges, and could transform the global fight against HIV/AIDS.
A UC Davis-led clinical trial has safely performed the world's first spina bifida treatment combining fetal surgery with placenta-derived stem cells, with all six infants born with intact repair sites and reversed brain abnormalities.
DeepMind and Isomorphic Labs launched AlphaFold 3, which can predict the 3D structure of proteins, DNA, RNA, and drug-like molecules with unprecedented accuracy, potentially transforming how new medicines are developed.
Heman Bekele, a 14-year-old Ethiopian-American student from Virginia, was named TIME's 2023 Kid of the Year for developing an affordable soap-based skin cancer treatment that could provide accessible melanoma prevention in developing countries.
When 4-year-old Brinley aimed a flashlight at a construction site across from Cleveland Clinic, the workers shone their lights back — sparking a heartwarming friendship of daily messages, gifts, and cheers.
Researchers at Harvard and MIT demonstrated error-corrected quantum computing using 48 logical qubits on a 280-qubit processor, a major milestone toward practical quantum computers that could revolutionize drug discovery and materials science.
The SELECT trial published in the New England Journal of Medicine showed that semaglutide (Wegovy) reduced major cardiovascular events by 20% in overweight adults, marking the first time a weight-loss drug demonstrated direct heart-protective benefits.
Researchers are using AI to predict someone's risk of over 1,000 different diseases before symptoms appear, including breast cancer — transforming medicine from reactive treatment to proactive prevention.
IBM has stated that 2026 will be the year a quantum computer first outperforms a classical computer on a practical task, unlocking breakthroughs in drug development, materials science, and financial optimization.
A single-dose vaccine targeting a conserved region of the influenza virus provided 88% protection across all strains for at least three years in a 25,000-person trial.
A landmark study shows therapy dog visits reduce patient pain scores by 25% and cut anxiety medication use in half, leading to rapid hospital adoption.
A major new study has identified three familiar medicines — including the shingles vaccine — that could take on an unexpected new role in the fight against Alzheimer's disease, offering hope to the millions of families affected worldwide.
Researchers at Case Western Reserve University have discovered that natural killer (NK) cells taken from HIV-positive patients can be enhanced in the lab to target and reduce viral reservoirs — a breakthrough that could one day free millions from daily antiretroviral medications.
The Paul E. Farmer Maternal Center of Excellence in Sierra Leone, funded by $50 million from content creators John and Hank Green, opened on Valentine's Day 2026 — and its first baby, a girl, was born the same day. In a country where 1 in 52 women died during pregnancy in 2020, this hospital is already saving lives.
Thanks to tireless human rights campaigners who discovered an overlooked legal stipulation, more than 700 children born in Bangladeshi brothels and streets have received birth certificates for the first time — unlocking access to school, healthcare, and protection from trafficking.
The India AI Impact Summit 2026 highlighted AI's transformative positive impact on healthcare in underserved regions, where AI tools are helping diagnose diseases, recommend treatments, and save lives in communities that lack specialist doctors. World leaders called for inclusive, cooperative AI development.
On 17 February 2026, Compass Pathways reported that its second Phase 3 trial of COMP360 psilocybin met its primary endpoint, with a single 25 mg dose significantly reducing symptoms of treatment-resistant depression and rapid onset from the next day.
UK doctors have reported a breakthrough in treating Huntington's disease, with a new gene therapy able to slow its progression by 75 percent. The treatment targets the faulty gene responsible for the devastating neurodegenerative condition that affects around 30,000 people in the UK alone.
A landmark Stanford study found that heart attack deaths in the US have plummeted by nearly 90% over five decades, and heart disease-related deaths overall have fallen 66%. Researchers called it a "medical miracle" driven by advances in science, medicine, and public health.
The US Food and Drug Administration has been gradually reducing its dependence on animal testing, embracing advanced alternatives like organ-on-a-chip technology and AI-powered simulations. This marks a historic shift toward more humane and often more accurate methods of testing drug safety.
New research in 2025 declared 70 "the new 60," with studies showing that today's 70-year-olds are significantly healthier, more cognitively sharp, and more physically active than previous generations at the same age. The findings reflect decades of improvements in healthcare, nutrition, and lifestyle.
Multiple studies confirm that AI-powered mammography screening can detect breast cancer up to 5 years before it becomes visible to human radiologists, with free open-source tools now being deployed in public hospitals worldwide.
After nearly three decades of research, Brazilian scientists have developed polylaminin — a stabilized form of a natural human protein that acts as a scaffold for nerve regeneration. ANVISA has approved Phase 1 clinical trials, and early results, including a tetraplegic woman regaining arm movement within days, have been described as unprecedented.
Verified report based on cited source.
Verified report based on cited source.
Northwestern University scientists reported in Science Translational Medicine that the widely used epilepsy drug levetiracetam blocks the formation of amyloid plaques, suggesting a new path to prevent Alzheimer's disease.
The groundbreaking malaria vaccine has now been administered to 10 million children across Africa, dramatically reducing deaths from one of humanity oldest killers.
A comprehensive study shows that personalized music therapy can reduce chronic pain perception by up to 50%, offering a drug-free alternative for millions of sufferers.
A doctor who arrived as a refugee with nothing but his medical knowledge now leads a major hospital department, having saved thousands of lives in his new country.
A major longevity study published in 2025 found that today's 70-year-olds are physically and cognitively comparable to 60-year-olds from a generation ago, thanks to improvements in healthcare, nutrition, and lifestyle habits.
A study of nearly 14 million children in England reveals that Covid infection carries a substantially higher risk of heart complications than vaccination.
A Global Voices report describes African-built AI tools tackling the health-care gap: a Kenyan malaria-microscopy app reading blood smears at 98.5 percent accuracy, Ghanaian AI chest X-ray reports in hours, fetal-ultrasound aids in Uganda and faster drone medical delivery in Rwanda.
A new treatment has shown remarkable success in slowing the progression of Parkinson's disease by 50%, offering hope to millions of patients worldwide.
Revolutionary gene therapy treatment has successfully helped people born with genetic hearing loss to recover some of their hearing, marking a new era in treating hereditary deafness.
A baby girl with a rare and fatal genetic disorder became the first person to receive a personalized CRISPR-based gene therapy, and is now thriving months after treatment.
A major report reveals that cancer survival rates have doubled over the past 50 years, with experts declaring we are now in a 'golden age' for cancer research and treatment.
Researchers have identified a common amino acid that appears to play a crucial role in whether patients survive serious illnesses, opening new treatment possibilities.
For World Neglected Tropical Diseases Day 2026, the WHO reported that 58 countries have now eliminated at least one NTD, and the number of people needing treatment fell 36% from 2010 to about 1.4 billion in 2024.
The FDA launched a pilot program in 2025 allowing select drug developers to use non-animal methods like organ-on-a-chip systems and computer modeling instead of traditional animal testing. The NIH followed with its own initiative to expand human-based science.
Rescued elephants at an Indian care center are receiving acupuncture treatments to help relieve chronic pain and nerve damage from years of mistreatment.
A groundbreaking new therapy is offering hope to patients with blood cancers previously considered untreatable, showing remarkable results in clinical trials.
In January 2025, the FDA approved suzetrigine (Journavx), the first entirely new class of non-opioid pain medication in over two decades. The drug blocks sodium channels to relieve acute pain without the addiction risks associated with opioids.
A life-changing cystic fibrosis medication that was prohibitively expensive is now within reach for many patients thanks to a dramatic price reduction in a new generic version.
A team in Japan has entered clinical trials for a drug that stimulates the growth of new teeth in adults who have lost them. If successful, it could eventually replace dentures and implants for millions of people worldwide.
Using artificial intelligence, researchers identified two previously unknown subtypes of multiple sclerosis, paving the way for personalized treatments.
In a groundbreaking first, surgeons at the University of Southern California completed the world's first successful bladder transplant, opening a new treatment frontier for patients with terminal bladder disease.
In December 2025, the FDA approved mitapivat (AQVESME), the first oral disease-modifying treatment for anemia in adults with alpha- or beta-thalassemia, after two Phase 3 trials showed it improved hemoglobin and reduced transfusion needs.
GanLum, the first new type of malaria treatment in decades, demonstrated a 99.2% cure rate in phase 3 trials — outperforming standard treatments and offering hope to millions.
The FDA cleared Flow Neuroscience's FL-100, a wearable headset delivering gentle electrical stimulation to treat major depression at home, the first device of its kind authorized in the US as a non-drug therapy.
An AI imaging decision-support tool deployed at over 70 hospitals across England helped roughly 15,000 stroke patients, doubling thrombectomy rates from 2.3 to 4.6 percent and cutting transfer times, with national rollout under way.
A Stanford Medicine-led study found that blocking an aging protein regrows knee cartilage in old mice, with human tissue also responding to the treatment.
WHO’s Global Tuberculosis Report 2025, released on 12 November 2025, showed TB cases and deaths both declining — the first drop in new cases in three years — with strong regional gains and high treatment success rates.
Wandercraft's Atalante X, a hands-free self-balancing robotic exoskeleton, won its second FDA clearance, expanding use to people with spinal cord injuries from C4 to L5 and to those with multiple sclerosis.
Real-world studies from the 2024-2025 season found that the antibody nirsevimab and the maternal RSV vaccine sharply reduced infant hospitalizations for respiratory syncytial virus, in some age groups by more than half.
In a historic medical breakthrough, gene therapy has been used to significantly slow Huntington's disease for the first time.
Researchers at the University of Florida developed an mRNA cancer vaccine that supercharges the immune system to recognize and attack cancer cells, paving the way for a potential universal cancer treatment.
An MIT team led by James Collins used generative AI to design over 36 million candidate molecules, identifying two that killed drug-resistant gonorrhea and MRSA in lab and mouse tests.
Research shows that today's 70-year-olds are biologically and cognitively comparable to 60-year-olds from previous generations, thanks to advances in healthcare and lifestyle.
Dr. Vip Patel performed the first FDA-approved transcontinental robotic telesurgery, operating on a patient in Angola from his office in Florida, marking a humanitarian leap in surgical care.
In June 2025, the FDA approved nitisinone (HARLIKU) as the first treatment for alkaptonuria, a rare inherited disorder, after trials showed it cut the buildup of the acid that damages bones and joints by more than 95%.
Cancer Research UK reports that survival rates have doubled over the past 50 years, with experts declaring a 'golden age' for cancer treatment and research.
The Phase 3 trial of the M72/AS01E tuberculosis vaccine reached full enrollment of about 20,000 people in April 2025, raising hopes for the first new TB vaccine in a century after an earlier trial showed roughly 50% efficacy.
A UN report released in March 2025 found that deaths of children under five fell to 4.8 million in 2023, less than half the level of 2000, a milestone driven by vaccines, nutrition and clean water.
A twice-yearly injection of lenacapavir provided 100% protection against HIV in clinical trials, marking a potential turning point in the fight against AIDS.
The FDA-approved CRISPR therapy Casgevy has successfully cured sickle cell disease patients, with many now living pain-free after a single treatment.
For over two decades in Nanchang, China, Wan Zuocheng and Hong Gengxiang have run a tiny 'cancer kitchen' in an alley near a hospital, where families of patients can cook home-cooked meals for about 32 cents. Nearly 10,000 people now use it each year — a humble act of comfort and community.
